Susquehanna International Group, LLP Kura Oncology, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$18.57 - $23.23 $1.07 Million - $1.34 Million	-57,800 Reduced 72.07%	22,400 $437,000
Q2 2024 Aug 15, 2024	SELL	$17.53 - $22.98 $371,636 - $487,176	-21,200 Reduced 20.91%	80,200 $1.65 Million
Q1 2024 May 07, 2024	BUY	$13.42 - $23.53 $1.36 Million - $2.39 Million	101,400 New	101,400 $2.16 Million
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $101,971 - $148,294	10,600 Added 89.83%	22,400 $236,000
Q1 2023 May 16, 2023	SELL	$10.71 - $14.6 $123,165 - $167,900	-11,500 Reduced 49.36%	11,800 $144,000
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $1.19 Million - $1.79 Million	-106,000 Reduced 81.98%	23,300 $289,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $862,318 - $1.4 Million	71,800 Added 124.87%	129,300 $1.77 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $78,183 - $133,809	-7,300 Reduced 11.27%	57,500 $1.05 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $432,326 - $623,166	-36,700 Reduced 36.16%	64,800 $1.04 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $366,600 - $587,100	-30,000 Reduced 22.81%	101,500 $1.42 Million
Q2 2021 Aug 11, 2021	SELL	$20.85 - $29.88 $2.88 Million - $4.12 Million	-138,000 Reduced 51.21%	131,500 $2.74 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $4.29 Million - $6.78 Million	173,300 Added 180.15%	269,500 $7.62 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $1.48 Million - $2.13 Million	51,200 Added 113.78%	96,200 $3.14 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $405,870 - $762,936	24,900 Added 123.88%	45,000 $1.38 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $57,240 - $135,432	7,200 Added 55.81%	20,100 $328,000
Q4 2019 Feb 14, 2020	SELL	$12.97 - $15.94 $259,400 - $318,800	-20,000 Reduced 60.79%	12,900 $177,000
Q1 2019 May 15, 2019	BUY	$13.73 - $16.87 $451,717 - $555,023	32,900 New	32,900 $546,000
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $142,040 - $234,365	-13,400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $53,279 - $69,920	3,200 Added 31.37%	13,400 $235,000
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $150,960 - $191,760	10,200 New	10,200 $186,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$68.4 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.3 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$51.9 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.4 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$38.7 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account